US Stock MarketDetailed Quotes

XRTXF XORTX THERAPEUTICS INC

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Jun 13 09:30 ET
0Market Cap0.00P/E (TTM)

XORTX THERAPEUTICS INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
577.97%2.74M
291.09%3.38M
372.63%3.64M
180.62%3.65M
322.97%1.61M
6.03%404.88K
133.34%865.45K
360.17%770.45K
129.79%1.3M
130.68%380.34K
Selling and administrative expenses
4,218.72%793.87K
81.04%1.51M
58.94%1.2M
153.03%2.78M
257.48%1.17M
-92.84%18.38K
136.21%834.65K
370.40%752.42K
116.94%1.1M
107.24%328.14K
-General and administrative expense
4,218.72%793.87K
81.04%1.51M
58.94%1.2M
153.03%2.78M
257.48%1.17M
-92.84%18.38K
136.21%834.65K
370.40%752.42K
116.94%1.1M
107.24%328.14K
Research and development costs
403.26%1.92M
6,943.92%1.86M
17,604.34%2.44M
207.48%853.12K
202.32%430.95K
218.22%381.97K
112.20%26.42K
469.20%13.79K
595.43%277.46K
9,204.70%142.55K
Depreciation amortization depletion
536.06%28.79K
184.79%12.45K
12.65%4.78K
-12.51%17.88K
-7.80%4.74K
-12.18%4.53K
-14.17%4.37K
-15.96%4.24K
2.71%20.44K
2.62%5.14K
-Depreciation and amortization
536.06%28.79K
184.79%12.45K
12.65%4.78K
-12.51%17.88K
-7.80%4.74K
-12.18%4.53K
-14.17%4.37K
-15.96%4.24K
2.71%20.44K
2.62%5.14K
Other operating expenses
----
----
----
----
----
----
----
----
---95.49K
----
Operating profit
-577.97%-2.74M
-291.09%-3.38M
-372.63%-3.64M
-180.62%-3.65M
-322.97%-1.61M
-6.03%-404.88K
-133.34%-865.45K
-360.17%-770.45K
-129.79%-1.3M
-130.68%-380.34K
Net non-operating interest income expense
3,448.77%46.28K
2,358.20%15.02K
278.21%3.35K
58.57%-5.6K
-104.79%-1.67K
-64.72%-1.38K
77.46%-665
78.87%-1.88K
63.69%-13.51K
94.36%-815
Non-operating interest expense
----
----
----
-58.57%5.6K
----
----
----
----
-63.69%13.51K
-94.36%815
Total other finance cost
-3,448.77%-46.28K
-2,358.20%-15.02K
-278.21%-3.35K
----
----
--1.38K
--665
--1.88K
----
----
Other net income (expense)
114.29%1.14M
176.12%1.79M
115.33%214.79K
6,709.37%2M
15,057.31%10.7M
-18,721.59%-7.95M
605,193.46%647.66K
-1,079.09%-1.4M
211.43%29.41K
-606.77%-71.57K
Gain on sale of security
114.29%1.14M
176.12%1.79M
115.33%214.79K
67,540.63%2M
152,892.61%10.7M
-18,721.59%-7.95M
812.45%647.66K
-1,079.09%-1.4M
111.22%2.96K
30.81%-7.01K
Special income (charges)
----
----
----
--0
----
----
----
----
--26.45K
---64.56K
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--64.56K
----
-Less:Other special charges
----
----
----
----
----
----
----
----
---91.01K
--0
Income before tax
81.30%-1.56M
-623.92%-1.58M
-57.50%-3.42M
-28.62%-1.65M
2,108.78%9.09M
-1,866.21%-8.35M
41.55%-218.45K
-6,440.44%-2.17M
-104.04%-1.28M
-138.95%-452.73K
Income tax
Net income
81.30%-1.56M
-623.92%-1.58M
-57.50%-3.42M
-28.62%-1.65M
2,108.78%9.09M
-1,866.21%-8.35M
41.55%-218.45K
-6,440.44%-2.17M
-104.04%-1.28M
-138.95%-452.73K
Net income continuous Operations
81.30%-1.56M
-623.92%-1.58M
-57.50%-3.42M
-28.62%-1.65M
2,108.78%9.09M
-1,866.21%-8.35M
41.55%-218.45K
-6,440.44%-2.17M
-104.04%-1.28M
-138.95%-452.73K
Minority interest income
Net income attributable to the parent company
81.30%-1.56M
-623.92%-1.58M
-57.50%-3.42M
-28.62%-1.65M
2,108.78%9.09M
-1,866.21%-8.35M
41.55%-218.45K
-6,440.44%-2.17M
-104.04%-1.28M
-138.95%-452.73K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
81.30%-1.56M
-623.92%-1.58M
-57.50%-3.42M
-28.62%-1.65M
2,108.78%9.09M
-1,866.21%-8.35M
41.55%-218.45K
-6,440.44%-2.17M
-104.04%-1.28M
-138.95%-452.73K
Basic earnings per share
86.52%-0.12
-500.00%-0.12
0.00%-0.26
10.53%-0.17
1,800.00%1.02
-1,383.33%-0.89
82.96%-0.02
-4,521.40%-0.26
-58.33%-0.19
-2,207.69%-0.06
Diluted earnings per share
86.52%-0.12
-500.00%-0.12
0.00%-0.26
10.53%-0.17
1,800.00%1.02
-1,383.33%-0.89
82.96%-0.02
-4,521.40%-0.26
-58.33%-0.19
-2,207.69%-0.06
Dividend per share
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 577.97%2.74M291.09%3.38M372.63%3.64M180.62%3.65M322.97%1.61M6.03%404.88K133.34%865.45K360.17%770.45K129.79%1.3M130.68%380.34K
Selling and administrative expenses 4,218.72%793.87K81.04%1.51M58.94%1.2M153.03%2.78M257.48%1.17M-92.84%18.38K136.21%834.65K370.40%752.42K116.94%1.1M107.24%328.14K
-General and administrative expense 4,218.72%793.87K81.04%1.51M58.94%1.2M153.03%2.78M257.48%1.17M-92.84%18.38K136.21%834.65K370.40%752.42K116.94%1.1M107.24%328.14K
Research and development costs 403.26%1.92M6,943.92%1.86M17,604.34%2.44M207.48%853.12K202.32%430.95K218.22%381.97K112.20%26.42K469.20%13.79K595.43%277.46K9,204.70%142.55K
Depreciation amortization depletion 536.06%28.79K184.79%12.45K12.65%4.78K-12.51%17.88K-7.80%4.74K-12.18%4.53K-14.17%4.37K-15.96%4.24K2.71%20.44K2.62%5.14K
-Depreciation and amortization 536.06%28.79K184.79%12.45K12.65%4.78K-12.51%17.88K-7.80%4.74K-12.18%4.53K-14.17%4.37K-15.96%4.24K2.71%20.44K2.62%5.14K
Other operating expenses -----------------------------------95.49K----
Operating profit -577.97%-2.74M-291.09%-3.38M-372.63%-3.64M-180.62%-3.65M-322.97%-1.61M-6.03%-404.88K-133.34%-865.45K-360.17%-770.45K-129.79%-1.3M-130.68%-380.34K
Net non-operating interest income expense 3,448.77%46.28K2,358.20%15.02K278.21%3.35K58.57%-5.6K-104.79%-1.67K-64.72%-1.38K77.46%-66578.87%-1.88K63.69%-13.51K94.36%-815
Non-operating interest expense -------------58.57%5.6K-----------------63.69%13.51K-94.36%815
Total other finance cost -3,448.77%-46.28K-2,358.20%-15.02K-278.21%-3.35K----------1.38K--665--1.88K--------
Other net income (expense) 114.29%1.14M176.12%1.79M115.33%214.79K6,709.37%2M15,057.31%10.7M-18,721.59%-7.95M605,193.46%647.66K-1,079.09%-1.4M211.43%29.41K-606.77%-71.57K
Gain on sale of security 114.29%1.14M176.12%1.79M115.33%214.79K67,540.63%2M152,892.61%10.7M-18,721.59%-7.95M812.45%647.66K-1,079.09%-1.4M111.22%2.96K30.81%-7.01K
Special income (charges) --------------0------------------26.45K---64.56K
-Less:Impairment of capital assets --------------0------------------64.56K----
-Less:Other special charges -----------------------------------91.01K--0
Income before tax 81.30%-1.56M-623.92%-1.58M-57.50%-3.42M-28.62%-1.65M2,108.78%9.09M-1,866.21%-8.35M41.55%-218.45K-6,440.44%-2.17M-104.04%-1.28M-138.95%-452.73K
Income tax
Net income 81.30%-1.56M-623.92%-1.58M-57.50%-3.42M-28.62%-1.65M2,108.78%9.09M-1,866.21%-8.35M41.55%-218.45K-6,440.44%-2.17M-104.04%-1.28M-138.95%-452.73K
Net income continuous Operations 81.30%-1.56M-623.92%-1.58M-57.50%-3.42M-28.62%-1.65M2,108.78%9.09M-1,866.21%-8.35M41.55%-218.45K-6,440.44%-2.17M-104.04%-1.28M-138.95%-452.73K
Minority interest income
Net income attributable to the parent company 81.30%-1.56M-623.92%-1.58M-57.50%-3.42M-28.62%-1.65M2,108.78%9.09M-1,866.21%-8.35M41.55%-218.45K-6,440.44%-2.17M-104.04%-1.28M-138.95%-452.73K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 81.30%-1.56M-623.92%-1.58M-57.50%-3.42M-28.62%-1.65M2,108.78%9.09M-1,866.21%-8.35M41.55%-218.45K-6,440.44%-2.17M-104.04%-1.28M-138.95%-452.73K
Basic earnings per share 86.52%-0.12-500.00%-0.120.00%-0.2610.53%-0.171,800.00%1.02-1,383.33%-0.8982.96%-0.02-4,521.40%-0.26-58.33%-0.19-2,207.69%-0.06
Diluted earnings per share 86.52%-0.12-500.00%-0.120.00%-0.2610.53%-0.171,800.00%1.02-1,383.33%-0.8982.96%-0.02-4,521.40%-0.26-58.33%-0.19-2,207.69%-0.06
Dividend per share
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg